search
Back to results

The Effectiveness of Exercise Combined With Acceptance and Commitment Therapy for Chronic Pain (ExACT)

Primary Purpose

Chronic Pain

Status
Completed
Phase
Not Applicable
Locations
Ireland
Study Type
Interventional
Intervention
Supervised Exercise
Acceptance and Commitment Therapy
Sponsored by
University College Dublin
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Pain focused on measuring Acceptance and Commitment Therapy, Exercise, Psychology, Psychological therapy, Physiotherapy, Physical therapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults aged 18 years and over who have been diagnosed with chronic pain by a medical doctor
  • Presence of persistent pain of greater than 12 weeks
  • Ability to provide informed consent
  • Ability to communicate adequately in spoken and written english
  • Score of ≥ 3 on pain interference subscale of the Brief Pain Inventory

Exclusion Criteria:

  • Need for further diagnostic evaluation
  • Presence of major medical or psychiatric disorder which would impede ability to participate with treatment
  • Presence of active cancer or cancer related pain
  • Unstable inflammatory condition e.g. rheumatoid arthritis or gout
  • Surgical or pain interventional procedure (e.g. spinal cord stimulator, rhizotomy, intra-articular or epidural injection) during the last 3 months.
  • Concurrent participation, or participation in the previous 3 months with any form of psychological therapy, physiotherapy or supervised exercise intervention
  • Previous participation in any form of multidisciplinary pain management programme
  • Presence of substance misuse
  • Presence of any contraindication to participation in a gym or pool based exercise programme such as shortness of breath at rest, unstable diabetes or epilepsy, recent myocardial infarction, stroke, pulmonary embolism, asthma attack
  • Weight > 125 kg or waist circumference > 50 inches (restriction die to pool evacuation equipment)

Sites / Locations

  • Mater Misericordiae University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Combined Exercise and ACT treatment

Standalone supervised exercise

Arm Description

Participants will attend a weekly group-based multidisciplinary pain programme for a period of eight weeks. The programme will combine exercise with the psychological approach acceptance and commitment therapy (ACT).

Participants will attend a weekly group-based supervised exercise class for a period of eight weeks.

Outcomes

Primary Outcome Measures

Change in pain interference measured with the Brief Pain Inventory - Interference scale
The interference subscale of the Brief Pain Inventory is a seven item self-report questionnaire that measures the extent to which pain interferes with functions such as general activity, walking ability, normal work, mood, relations with people, enjoyment of life and sleep.

Secondary Outcome Measures

Change in pain interference measured with the Brief Pain Inventory Interference Scale
The interference subscale of the Brief Pain Inventory is a seven item self-report questionnaire that measures the extent to which pain interferes with functions such as general activity, walking ability, normal work, mood, relations with people, enjoyment of life and sleep.
Change in pain severity measured with the Brief Pain Inventory (BPI) Composite pain score
Pain Severity will be measured using the composite pain score of the BPI
Change in pain self efficacy measured with the Pain Self Efficacy Questionnaire (PSEQ)
The PSEQ is a ten item questionnaire which assesses an individual's confidence in their ability to perform a variety of activities or tasks despite pain.
Change in quality of life measured with the EQ-5D-5L
The EQ-5D-5L assesses quality of life in five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Change in fear of movement measured with the Tampa Scale for Kinesiophobia (TSK)
Fear of movement or re-injury has been reported to be a strong predictor of physical functioning and disability in chronic pain. The TSK is reported to be reliable and valid measure of fear of movement in individuals with chronic pain.
Change in pain catastrophising measured with the Pain Catastrophising Scale (PCS)
The PCS is a 13-item instrument designed to assess catastrophic thinking in relation to pain. The PCS yields a total score and three subscale scores assessing rumination, magnification and helplessness.
Change in pain acceptance measured with the Chronic Pain Acceptance Questionnaire (CPAQ - 8)
Pain acceptance is considered to be a treatment process variable and is regularly used in studies which feature ACT. The CPAQ-8 is a shortened version of the original 20-item CPAQ with two subscales; activity engagement and pain willingness.
Change in committed action measured with the Committed Action Questionnaire (CAQ-8)
Committed action is another treatment process variable which we propose to measure. The CAQ-8 is a shortened version of the original 18-item Committed Action Questionnaire which measures committed action in relation to commitment to valued goals.
Patient Global Impression of Change Scale (PGIC)
The PGIC scale measures a patient's rating of overall improvement or lack thereof due to the intervention.
Patient satisfaction with treatment measured with a single question from the Client Satisfaction Questionnaire-8
Satisfaction with treatment will be measured using a single question from the Client Satisfaction questionnaire (CSQ-8) which is designed to measure satisfaction with services. The question will ask "In an overall, general sense, how satisfied are you with the service you have received?" and four potential responses will be provided (very satisfied, mostly satisfied, indifferent or mildly dissatisfied and quite dissatisfied). The percentages of participants endorsing each of the responses will be reported.
Change in symptoms of depression measured using the Patient Health Questionnaire-9 (PHQ-9)
Symptoms of depression will be assessed using the PHQ-9, which is a nine-item questionnaire generating scores ranging from 0 - 27.
Change in symptoms of anxiety measured with the General Anxiety Disorder-7 questionnaire (GAD-7)
The GAD-7 assesses symptoms of anxiety experienced during the last two weeks.
Change in self-reported healthcare utilisation
This questionnaire will collect data related to healthcare utilisation during the preceding three month period including GP visits, hospital consultant visits, visits to alternative health care practitioners, emergency department visits and number of nights of hospital in-patient stay.
Change in physical activity levels (average weekly step count, distance travelled and active minutes)
Average weekly step count, distance travelled and active minutes will be measured using a FitBit Zip activity tracker for one week prior to randomisation and for the duration of the eight week intervention.

Full Information

First Posted
February 6, 2017
Last Updated
November 10, 2020
Sponsor
University College Dublin
Collaborators
Mater Misericordiae University Hospital, Health Research Board, Ireland, King's College London
search

1. Study Identification

Unique Protocol Identification Number
NCT03050528
Brief Title
The Effectiveness of Exercise Combined With Acceptance and Commitment Therapy for Chronic Pain
Acronym
ExACT
Official Title
The ExACT Trial: The Effectiveness of Exercise Combined With Acceptance and Commitment Therapy Compared to a Standalone Supervised Exercise Intervention for Chronic Pain. A Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
February 6, 2017 (Actual)
Primary Completion Date
December 30, 2018 (Actual)
Study Completion Date
December 30, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University College Dublin
Collaborators
Mater Misericordiae University Hospital, Health Research Board, Ireland, King's College London

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to evaluate the effectiveness of a combined Exercise and Acceptance and Commitment Therapy (ACT) programme, compared to a standalone supervised exercise intervention for patients with chronic pain. Chronic pain is a common problem, which can have a significant impact on quality of life. While there are many treatments available for chronic pain, research has shown that improvements are often modest and short-term. Exercise therapy is known to be helpful for many chronic conditions and is recommended in clinical guidelines for the management of chronic pain. Acceptance and Commitment Therapy (ACT) is a form of psychological therapy, which focuses on improvement of function, rather than symptom reduction. There is an emphasis on psychological flexibility, values and mindfulness. This approach may be well suited to chronic pain, where symptoms can be beyond a person's control, but there is a need for further research, particularly with regards to combining ACT with a physical intervention. This study will take place in a Dublin University hospital. Patients will be randomly allocated to a combined exercise and ACT treatment group or a standalone exercise group. Both groups will have weekly treatment for eight weeks and will be assessed before and after treatment, and again twelve weeks later. Questionnaires will be used to measure the effects of the treatment on the degree to which pain interferes with various aspects of daily life. Activity trackers will be worn to measure daily physical activity levels. A purposeful sample of participants from both groups will also be invited to participate in a qualitative study following treatment.
Detailed Description
This prospective, two-armed, parallel group, single-centre Randomised Controlled Trial (RCT) will assess the effectiveness of a combined Exercise and ACT programme, in comparison to a standalone supervised exercise intervention for chronic pain. One hundred and sixty patients aged 18 years and over, who have been diagnosed with a chronic pain condition by a medical doctor will be recruited to the trial. Participants will be individually randomised to one of two group interventions. The combined group will take part in eight, weekly psychology sessions based on the ACT approach, in addition to supervised exercise classes led by a physiotherapist. The control group will also attend eight, weekly supervised exercise classes but will not take part in ACT programme. All participants will be assessed at baseline, immediately post intervention and at twelve-week follow-up. The primary outcome will be pain interference at twelve-week follow-up, measured using the Brief Pain Inventory-Interference Scale. Secondary outcomes will include self-reported pain severity, pain related self-efficacy, quality of life, kinesiophobia, pain catastrophizing, pain acceptance, committed action, patient global impression of change, patient satisfaction with treatment, depression and anxiety. The number of investigations and pain related visits to healthcare professionals in the preceding three months will be recorded at baseline and twelve-week follow-up. Physical activity levels (average daily step count, distance travelled and active minutes) will be measured for all participants using Fitbit Zip activity trackers for one week prior to starting treatment and for the duration of the eight week intervention period. Participants will be invited to wear the activity trackers for one further week at the twelve-week follow-up time point. Estimates of treatment effects at follow up time-points will be based on an intention-to-treat framework, implemented using a linear mixed effects model. A purposeful sample of participants will be invited to attend individual interviews and focus groups, twelve weeks following completion of the interventions. Semi-structured interviews will be conducted, with the aim of exploring the views of participants of both interventions in order to enhance understanding of how these types of interventions work.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Pain
Keywords
Acceptance and Commitment Therapy, Exercise, Psychology, Psychological therapy, Physiotherapy, Physical therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Masking Description
The academic Statistician (Dr Ricardo Segurado) and the Senior Researcher (Maire-Brid Casey) will be blind to group allocation. Dr Segurado will be responsible for data analysis. Máire-Bríd Casey will be responsible for data entry and will assist with data analysis.
Allocation
Randomized
Enrollment
175 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Combined Exercise and ACT treatment
Arm Type
Experimental
Arm Description
Participants will attend a weekly group-based multidisciplinary pain programme for a period of eight weeks. The programme will combine exercise with the psychological approach acceptance and commitment therapy (ACT).
Arm Title
Standalone supervised exercise
Arm Type
Active Comparator
Arm Description
Participants will attend a weekly group-based supervised exercise class for a period of eight weeks.
Intervention Type
Behavioral
Intervention Name(s)
Supervised Exercise
Intervention Description
Participants will attend the weekly supervised exercise sessions for a period of eight weeks. The classes will be delivered to groups of up to ten participants and will be led by a physiotherapist. The classes will be one hour and thirty minutes in duration and will feature two components: education/advice and exercise. The education/advice sessions will cover topics such as pacing and goal setting and the physiotherapist will answer any queries from the participants in relation to physical activity over the course of the eight weeks. The exercise component will involve the provision of individualised exercises based on each participant's personal goals and the sessions will feature a combination of aerobic, stretching and strengthening exercise in a pool and a gym setting.
Intervention Type
Behavioral
Intervention Name(s)
Acceptance and Commitment Therapy
Intervention Description
Participants will attend weekly group psychology sessions for an eight-week period. Each session will be two hours in duration and will delivered by a Senior Psychologist trained in Acceptance and Commitment Therapy (ACT). The sessions will feature an ACT treatment process that is designed to promote psychological flexibility through various methods including acceptance and values awareness. The overall aim is to promote behaviour change, enhancing patient engagement in meaningful activities and reducing pain-avoidant behaviours. There is an emphasis on mindfulness, experiential learning and the use of metaphor which is unique to ACT.
Primary Outcome Measure Information:
Title
Change in pain interference measured with the Brief Pain Inventory - Interference scale
Description
The interference subscale of the Brief Pain Inventory is a seven item self-report questionnaire that measures the extent to which pain interferes with functions such as general activity, walking ability, normal work, mood, relations with people, enjoyment of life and sleep.
Time Frame
12 week follow up (20 weeks from baseline assessment)
Secondary Outcome Measure Information:
Title
Change in pain interference measured with the Brief Pain Inventory Interference Scale
Description
The interference subscale of the Brief Pain Inventory is a seven item self-report questionnaire that measures the extent to which pain interferes with functions such as general activity, walking ability, normal work, mood, relations with people, enjoyment of life and sleep.
Time Frame
immediately post intervention (8 weeks from baseline)
Title
Change in pain severity measured with the Brief Pain Inventory (BPI) Composite pain score
Description
Pain Severity will be measured using the composite pain score of the BPI
Time Frame
immediately post intervention (8 weeks from baseline) and 12 week follow up (20 weeks from baseline)
Title
Change in pain self efficacy measured with the Pain Self Efficacy Questionnaire (PSEQ)
Description
The PSEQ is a ten item questionnaire which assesses an individual's confidence in their ability to perform a variety of activities or tasks despite pain.
Time Frame
Immediately post intervention (8 weeks from baseline) and 12 week follow up (20 weeks from baseline)
Title
Change in quality of life measured with the EQ-5D-5L
Description
The EQ-5D-5L assesses quality of life in five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Time Frame
Immediately post intervention (8 weeks from baseline) and 12 week follow up (20 weeks from baseline)
Title
Change in fear of movement measured with the Tampa Scale for Kinesiophobia (TSK)
Description
Fear of movement or re-injury has been reported to be a strong predictor of physical functioning and disability in chronic pain. The TSK is reported to be reliable and valid measure of fear of movement in individuals with chronic pain.
Time Frame
Immediately post intervention (8 weeks from baseline) and 12 week follow up (20 weeks from baseline)
Title
Change in pain catastrophising measured with the Pain Catastrophising Scale (PCS)
Description
The PCS is a 13-item instrument designed to assess catastrophic thinking in relation to pain. The PCS yields a total score and three subscale scores assessing rumination, magnification and helplessness.
Time Frame
Immediately post intervention (8 weeks from baseline) and 12 week follow up (20 weeks from baseline)
Title
Change in pain acceptance measured with the Chronic Pain Acceptance Questionnaire (CPAQ - 8)
Description
Pain acceptance is considered to be a treatment process variable and is regularly used in studies which feature ACT. The CPAQ-8 is a shortened version of the original 20-item CPAQ with two subscales; activity engagement and pain willingness.
Time Frame
Immediately post intervention (8 weeks from baseline) and 12 week follow up (20 weeks from baseline)
Title
Change in committed action measured with the Committed Action Questionnaire (CAQ-8)
Description
Committed action is another treatment process variable which we propose to measure. The CAQ-8 is a shortened version of the original 18-item Committed Action Questionnaire which measures committed action in relation to commitment to valued goals.
Time Frame
Immediately post intervention (8 weeks from baseline) and 12 week follow up (20 weeks from baseline)
Title
Patient Global Impression of Change Scale (PGIC)
Description
The PGIC scale measures a patient's rating of overall improvement or lack thereof due to the intervention.
Time Frame
Immediately post intervention (8 weeks from baseline)
Title
Patient satisfaction with treatment measured with a single question from the Client Satisfaction Questionnaire-8
Description
Satisfaction with treatment will be measured using a single question from the Client Satisfaction questionnaire (CSQ-8) which is designed to measure satisfaction with services. The question will ask "In an overall, general sense, how satisfied are you with the service you have received?" and four potential responses will be provided (very satisfied, mostly satisfied, indifferent or mildly dissatisfied and quite dissatisfied). The percentages of participants endorsing each of the responses will be reported.
Time Frame
Immediately post intervention (8 weeks from baseline)
Title
Change in symptoms of depression measured using the Patient Health Questionnaire-9 (PHQ-9)
Description
Symptoms of depression will be assessed using the PHQ-9, which is a nine-item questionnaire generating scores ranging from 0 - 27.
Time Frame
Immediately post intervention (8 weeks from baseline) and 12 week follow up (20 weeks from baseline)
Title
Change in symptoms of anxiety measured with the General Anxiety Disorder-7 questionnaire (GAD-7)
Description
The GAD-7 assesses symptoms of anxiety experienced during the last two weeks.
Time Frame
Immediately post intervention (8 weeks from baseline) and 12 week follow up (20 weeks from baseline)
Title
Change in self-reported healthcare utilisation
Description
This questionnaire will collect data related to healthcare utilisation during the preceding three month period including GP visits, hospital consultant visits, visits to alternative health care practitioners, emergency department visits and number of nights of hospital in-patient stay.
Time Frame
Immediately post intervention (8 weeks from baseline) and 12 week follow up (20 weeks from baseline)
Title
Change in physical activity levels (average weekly step count, distance travelled and active minutes)
Description
Average weekly step count, distance travelled and active minutes will be measured using a FitBit Zip activity tracker for one week prior to randomisation and for the duration of the eight week intervention.
Time Frame
Immediately post intervention (8 weeks from baseline) and 12 week follow up (20 weeks from baseline)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults aged 18 years and over who have been diagnosed with chronic pain by a medical doctor Presence of persistent pain of greater than 12 weeks Ability to provide informed consent Ability to communicate adequately in spoken and written english Score of ≥ 3 on pain interference subscale of the Brief Pain Inventory Exclusion Criteria: Need for further diagnostic evaluation Presence of major medical or psychiatric disorder which would impede ability to participate with treatment Presence of active cancer or cancer related pain Unstable inflammatory condition e.g. rheumatoid arthritis or gout Surgical or pain interventional procedure (e.g. spinal cord stimulator, rhizotomy, intra-articular or epidural injection) during the last 3 months. Concurrent participation, or participation in the previous 3 months with any form of psychological therapy, physiotherapy or supervised exercise intervention Previous participation in any form of multidisciplinary pain management programme Presence of substance misuse Presence of any contraindication to participation in a gym or pool based exercise programme such as shortness of breath at rest, unstable diabetes or epilepsy, recent myocardial infarction, stroke, pulmonary embolism, asthma attack Weight > 125 kg or waist circumference > 50 inches (restriction die to pool evacuation equipment)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maire-Brid Casey, BSc, MMT
Organizational Affiliation
University College Dublin
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mater Misericordiae University Hospital
City
Dublin
ZIP/Postal Code
7
Country
Ireland

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
16095934
Citation
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287-333. doi: 10.1016/j.ejpain.2005.06.009. Epub 2005 Aug 10.
Results Reference
background
PubMed Identifier
22300900
Citation
Raftery MN, Ryan P, Normand C, Murphy AW, de la Harpe D, McGuire BE. The economic cost of chronic noncancer pain in Ireland: results from the PRIME study, part 2. J Pain. 2012 Feb;13(2):139-45. doi: 10.1016/j.jpain.2011.10.004.
Results Reference
background
PubMed Identifier
23152245
Citation
Williams AC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD007407. doi: 10.1002/14651858.CD007407.pub3.
Results Reference
background
PubMed Identifier
21251756
Citation
Veehof MM, Oskam MJ, Schreurs KMG, Bohlmeijer ET. Acceptance-based interventions for the treatment of chronic pain: a systematic review and meta-analysis. Pain. 2011 Mar;152(3):533-542. doi: 10.1016/j.pain.2010.11.002. Epub 2011 Jan 19.
Results Reference
background
PubMed Identifier
21683527
Citation
Wetherell JL, Afari N, Rutledge T, Sorrell JT, Stoddard JA, Petkus AJ, Solomon BC, Lehman DH, Liu L, Lang AJ, Atkinson HJ. A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain. Pain. 2011 Sep;152(9):2098-2107. doi: 10.1016/j.pain.2011.05.016. Epub 2011 Jun 17.
Results Reference
background
PubMed Identifier
34913883
Citation
Casey MB, Smart KM, Segurado R, Hearty C, Gopal H, Lowry D, Flanagan D, McCracken L, Doody C. Exercise combined with Acceptance and Commitment Therapy compared with a standalone supervised exercise programme for adults with chronic pain: a randomised controlled trial. Pain. 2022 Jun 1;163(6):1158-1171. doi: 10.1097/j.pain.0000000000002487. Epub 2021 Sep 24.
Results Reference
derived
PubMed Identifier
29566744
Citation
Casey MB, Smart K, Segurado R, Hearty C, Gopal H, Lowry D, Flanagan D, McCracken L, Doody C. Exercise combined with Acceptance and Commitment Therapy (ExACT) compared to a supervised exercise programme for adults with chronic pain: study protocol for a randomised controlled trial. Trials. 2018 Mar 22;19(1):194. doi: 10.1186/s13063-018-2543-5.
Results Reference
derived

Learn more about this trial

The Effectiveness of Exercise Combined With Acceptance and Commitment Therapy for Chronic Pain

We'll reach out to this number within 24 hrs